Ticker Launch
Sign inTry it free

SPAC · Merger completed

Maxpro Capital Acquisition Corp.

Business combination with Apollomics Inc.

Maxpro Capital Acquisition Corp. is a blank-check company (SPAC) that raised $90M in its initial public offering on Oct 8, 2021, listing on Nasdaq Global Market. It completed its business combination with Apollomics Inc. on Mar 29, 2023; the combined company is Apollomics Inc.. Benchmark led the IPO. Nelson Mullins advised the SPAC and Loeb & Loeb advised the underwriters on the IPO.

Apollomics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing oncology therapies. They are intended to be combined with other treatments to harness the immune system and target specific molecular pathways to inhibit cancer.

Status
Merger completed
IPO date
Oct 8, 2021
IPO size
$90M
IPO exchange
Nasdaq Global Market
Target
Apollomics Inc. (Apollomics)
Announced
Oct 14, 2022
Closed
Mar 29, 2023
Combined company
Apollomics Inc.
IPO underwriters
Benchmark
SPAC counsel (IPO)
Nelson Mullins
Underwriters' counsel (IPO)
Loeb & Loeb

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Try it free for 7 daysOpen in Ticker Launch

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2023